CFU-E
Colony-Forming Unit-Erythroid (CFU-E)[edit]
The Colony-Forming Unit-Erythroid (CFU-E) is a crucial stage in the hematopoietic process, specifically in the development of red blood cells. CFU-E is a progenitor cell that arises from the common myeloid progenitor and is committed to the erythroid lineage. This stage is characterized by its sensitivity to erythropoietin (EPO), a hormone that regulates red blood cell production.
Developmental Pathway[edit]
The development of CFU-E is part of the broader process of erythropoiesis, which is the production of red blood cells. The pathway begins with the hematopoietic stem cell (HSC), which differentiates into a common myeloid progenitor (CMP). From the CMP, the cell further differentiates into a burst-forming unit-erythroid (BFU-E), which eventually gives rise to the CFU-E.
CFU-E cells are highly responsive to erythropoietin, which stimulates their proliferation and differentiation into proerythroblasts. These proerythroblasts then undergo several stages of maturation, eventually becoming mature erythrocytes.
Role of Erythropoietin[edit]
Erythropoietin is a glycoprotein hormone produced primarily by the kidneys in response to low oxygen levels in the blood. It plays a critical role in the survival, proliferation, and differentiation of CFU-E cells. Erythropoietin binds to its receptor on the surface of CFU-E cells, activating signaling pathways that prevent apoptosis and promote cell division and maturation.
Clinical Significance[edit]
The regulation of CFU-E and erythropoiesis is vital for maintaining adequate levels of red blood cells and ensuring proper oxygen transport throughout the body. Disorders in this process can lead to conditions such as anemia, where there is a deficiency of red blood cells, or polycythemia, where there is an excess.
Therapeutically, recombinant erythropoietin is used to treat anemia, particularly in patients with chronic kidney disease or those undergoing chemotherapy, as these conditions can impair the body's natural erythropoietin production.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian